Investigational New Drug (IND)-enabling and Early-Stage Development of Medications to Treat Alcohol Use disorder and Alcohol-Associated Organ Damage (U43/U44 Clinical Trial Optional)
This grant opportunity is for small businesses aiming to develop therapeutic treatments for alcohol use disorder (AUD) or alcohol-induced organ damage. Applicants must have a therapeutic candidate with solid scientific data ready to move into preclinical and clinical development phases. The project can focus on any stage of drug development from late discovery through early-stage clinical tria…
Source
Dates
Program & Phase
Keywords
Supporting Links
Documents
Similar Opportunities
-
Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed)
National Institutes of Health
-
Minor Use Minor Species Development of Drugs (R01)
Food and Drug Administration
-
DoW Autism Clinical Trial Award
Dept. of the Army -- USAMRAA
-
Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)
National Institutes of Health
-
Development of Interventions to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional)
National Institute on Drug Abuse
Find tens of thousands more opportunities — free
Scout accounts are free. Sign up to browse the full funding database, unlock the solicitation links and documents for this opportunity, and see how well each one fits your organization.
-
Tens of thousands of funding opportunities
Search and filter every grant and solicitation in Scout — all free, no credit card required.
-
Instant Fit Analysis
Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
-
Source links & full documents
Jump straight to the solicitation and download every attachment.
-
Save opportunities & track deadlines
Keep the opportunities that fit in one place and stay ahead of every due date.
Already have an account? Sign In
Trusted by 500+ Happy Customers